Aberrant tyrosinase expression in an atypical fibroxanthoma: A case report

被引:1
作者
Weiss, Amy [1 ]
Vanchinathan, Vijay [2 ]
Kwon, Eun J. [2 ,3 ]
机构
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[2] Rutgers State Univ, Div Dermatol, New Jersey Med Sch, Newark, NJ USA
[3] Dermpath Diagnost New York, 100 Midland Ave, Port Chester, NY 10573 USA
关键词
atypical fibroxanthoma; immunohistochemistry; MART-1; melan-A; tyrosinase; DIAGNOSTIC UTILITY; CD10; P63; KERATIN; VARIANT; MARKER; TUMORS; CELLS;
D O I
10.1111/cup.12900
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atypical fibroxanthoma (AFX) is a histologic mimicker of a variety of spindle cell neoplasms, and careful microscopic and immunohistochemical evaluation is critical in establishing the correct diagnosis. Here we report the histologic and immunohistochemical work up of a 1cm nodule involving the left dorsal hand of a 66-year-old patient. Light microscopy revealed fascicles of spindled and pleomorphic cells within the dermis showing increased mitotic activity occurring in the background of sun-damaged skin. There were numerous multinucleated cells with hyperchromatic nuclei and ample finely vacuolated or foamy cytoplasms. There was strong and diffuse CD10 and patchy CD68 expression among the spindled cells and multinucleated cells. The neoplastic cells did not show immunoreactivity against S100, p75-NGFR, HMB-45 or a panel of keratinocytic, vascular and smooth muscle markers. Tyrosinase and Melan-A were not expressed within the spindle cell component of this neoplasm; however, there was tyrosinase expression among numerous multinucleated giant cells. Melan-A expression was also observed among rare multinucleated giant cells. Tyrosinase expression has not previously been reported in AFX.
引用
收藏
页码:467 / 469
页数:3
相关论文
共 22 条
  • [1] Boyle JL, 2002, ARCH PATHOL LAB MED, V126, P816
  • [2] Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma
    Bull, Christian
    Mirzabeigi, Marjan
    Laskin, William
    Dubina, Meghan
    Traczyc, Tom
    Guitart, Joan
    Gerami, Pedram
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (08) : 631 - 635
  • [3] Role of CD10, Wide-Spectrum Keratin, p63, and Podoplanin in the Distinction of Epithelioid and Spindle Cell Tumors of the Skin: An Immunohistochemical Study of 81 Cases
    Buonaccorsi, J. Noelle
    Plaza, Jose A.
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (04) : 404 - 411
  • [4] HMB-45 expression in a clear cell variant of atypical fibroxanthoma
    Cai, JP
    Randall, MB
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (02) : 186 - 188
  • [5] Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma
    De Feraudy, Sebastien
    Mar, Natalie
    McCalmont, Timothy H.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (08) : 1111 - 1122
  • [6] Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis, Ransom
    Chase, Elizabeth
    Barland, Alycia
    Rajpara, Anand
    Fraga, Garth R.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2015, 42 (11) : 847 - 852
  • [7] Hall JM, 2008, INT J CLIN EXP PATHO, V1, P524
  • [8] Harding-Jackson N, 2015, AM J DERMATOPATH, V37, P15
  • [9] Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX
    Harding-Jackson, Nicholas
    Sangueza, Martin
    Mackinnon, Alexander
    Suster, Saul
    Plaza, Jose A.
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2015, 37 (07) : 509 - 516
  • [10] Immunohistochemical staining of CD10 in atypical fibroxanthomas
    Hultgren, Tricia L.
    DiMaio, Dominick J.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (05) : 415 - 419